TPTX » Topics » IN WITNESS WHEREOF

This excerpt taken from the TPTX 8-K filed Dec 15, 2009.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and year first above written.
 

 
RAPTOR PHARMACEUTICAL CORP.
 
By:                                                                           
 
Name:
 
Its:                                                                           
 

 
Agent
 
Name:
 
Print Name:                                                                           
 
Address:                                                                           
 

 

 

 















 
 
 

This excerpt taken from the TPTX 10-K filed Mar 29, 2007.
In Witness Whereof, the Company has caused this Warrant to be executed by its duly authorized officer as of October 3, 2006.

TorreyPines Therapeutics, Inc.

 

 

 

By:

 

 

 

 

Name:

 

 

 

 

Title:

 

 

 

 

Address:

11085 North Torrey Pines Road

 

 

Suite 300

 

 

La Jolla, CA 92037

 

 

Telephone: (858) 623-5665

 

 

Fax: (858) 623-5666

 

 

Attention: Chief Financial Officer

 

7




These excerpts taken from the TPTX 8-K filed Dec 20, 2006.
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first shown above.

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

 

/s/ Neil Kurtz

 

NEIL M. KURTZ, M.D.

 

CHIEF EXECUTIVE OFFICER AND PRESIDENT

 

 

 

 

 

 

 

EXECUTIVE

 

 

 

/s/ Evelyn Graham

 

EVELYN GRAHAM

 

CHIEF OPERATING OFFICER

 

 

12




IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first shown above.

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

 

/s/ Jean Deleage

 

JEAN DELEAGE, PH.D.

 

CHAIRMAN OF THE BOARD OF DIRECTORS

 

 

 

 

 

 

 

EXECUTIVE

 

 

 

/s/ Neil Kurtz

 

NEIL M. KURTZ, M.D.

 

CHIEF EXECUTIVE OFFICER, PRESIDENT

 

 

12




IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first shown above.

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

 

/s/ Neil Kurtz

 

NEIL M. KURTZ, M.D.

 

CHIEF EXECUTIVE OFFICER AND PRESIDENT

 

 

 

 

 

 

 

EXECUTIVE

 

 

 

/s/ Craig Johnson

 

CRAIG JOHNSON

 

CHIEF FINANCIAL OFFICER AND VICE PRESIDENT, FINANCE

 

 

12




These excerpts taken from the TPTX 8-K filed Oct 10, 2006.
IN WITNESS WHEREOF, the parties hereto have entered into this Agreement effective as of the date first above written.

 

 

COMPANY

 

 

 

 

 

 

TorreyPines Therapeutics, Inc., a Delaware

 

corporation

 

 

 

 

 

 

 

By:

 

 

 

Name:

 

 

 

Title:

 

 

 

 

 

 

 

 

INDEMNITEE

 

 

 

 

 

Signature of Indemnitee

 

 

 

 

 

Print or Type Name of Indemnitee

 

10


IN WITNESS WHEREOF, the Parties through their authorized representatives, have executed this Agreement as of the Effective Date.

 

 

NEUROGENETICS, INC.

 

 

 

 

 

 

 

 

 

By:

 

/s/Neil Kurtz

 

 

Name:

 

Neil M. Kurtz, M.D

 

 

Title:

 

President and CEO

 

 



 

 

EISAI CO., Ltd.

 

 

 

 

By:

 

/s. Kentaro Yoshimatsu

 

 

Name:

 

Kentaro Yoshimatsu

 

 

Title:

 

Senior Vice President

 

 

Discovery & Development Research

 

 



 

IN WITNESS WHEREOF, the parties hereto have duly executed this RESEARCH AND LICENSE AGREEMENT, including the Exhibit attached hereto and incorporated herein by reference.

 

LIFE SCIENCE RESEARCH ISRAEL LTD.

NEUROGENETICS, INC.

 

 

 

 

By:

 

/s/ Avigdor Shafferman

 

By:

 

/s/ Neil Kurtz

 

 

Name:

Avigdor Shafferman

 

Name:

Neil M. Kurtz, M.D.

 

 

Title:

Chairman

 

Title:

 

President and CEO

 

 

 

[SIGNATURE PAGE TO RESEARCH AND LICENSE AGREEMENT]

 



 

IN WITNESS WHEREOF, the Parties by their respective authorized representatives, have executed this Agreement.

 

 

ELI LILLY AND COMPANY

 

 

 

 

 

By:

Signature illegible

 

 

 

 

Printed:

Signature illegible

 

 

 

 

Title:

Executive Vice President

 

 

 

 

NEUROGENETICS, INC.

 

 

 

 

 

By:

/s/Neil Kurtz

 

 

 

 

Printed:

Neil M. Kurtz, M.D.

 

 

 

 

Title:

President and CEO

 

 

34



 

This excerpt taken from the TPTX 8-K filed Jun 30, 2005.
IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the date first written above.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki